Revision history of "Chronic Vardenafil Remedy Has CV Advantages In Type 2 Diabetes"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 03:30, 19 July 2019ElizabetBurden2 (talk | contribs). . (5,996 bytes) (+5,996). . (Created page with "<br> DUBLIN — Chronic remedy with the phosphodiesterase-5 (PDE-5) inhibitor vardenafil (Levitra, Bayer/GlaxoSmithKline) for 6 months in males with type 2 diabetes is secu...")